“Together we can make a difference” METHADONE “A life saving medication” Maryland NAMA is the National Alliance of Methadone Advocates (NAMA) official chapter for the state of Maryland. NAMA is a world wide organization dedicated to the betterment of treatment for all methadone patients. Join us in the struggle! NAMA’s Goals To eliminate discrimination toward…

United States Regulations Code of Federal Regulations 42 Part 8. Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction. Federal Register 17 January 2001. (PDF Format) Publication of Final Rule with comments. 42 Code of Federal Regulations Part 2 . Confidentiality of Alcohol and Drug Abuse Patient Records. New Take Home Regulations. Page 4098…

NAMA at National Methadone Conference – AMTA 2001 Wednesday, October 10th Moderator, Howard Lotsof, NAMA Acting Membership Director Gary Nessenbaum, Washington Advocates for Methadone Maintenance (President). The Patients’ Perspectives on the Changes in the Methadone Treatment System. Carmen Pearman, NAMA Regional Director and The MAG of Indiana (President). Tapering – The Last Ten Milligrams. Jo…

NAMA NorthEast Recovery Serving the New England Region Massachusetts, Maine, Rhode Island Connecticuit, New Hampshire and Vermont Welcome to Our Web Site! Powered by RingSurf! This website is for Methadone Patients and all Patients in Medication Assisted Treatment. NAMA NorthEast Recovery Includes Program Staff and Healthcare Professionals. We Believe That We Have A Lot To…

FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

New Methadone Regulations The comment period is now over. CSAT has formed a committee to review the comments and the regulations. A short meeting is planned for January 31, 2000. Two NAMA officers are on the committee Lisa Torres, Esq. and Joycelyn Woods. Buprenorphrine Committee A federal committee has been formed to review the guidelines…